Skip to main content
. Author manuscript; available in PMC: 2017 Dec 15.
Published in final edited form as: Cancer Res. 2017 Apr 20;77(12):3244–3254. doi: 10.1158/0008-5472.CAN-16-2355

Figure 6.

Figure 6

Mechanism of miR-34a regulation in vivo. E-cadherin, Ki-67, cyclin D1, SIRT-1, Tap73, and Elk-1 expression after PTX and rubone formulation therapy was determined by IHC (Scale bar, 200 μM for backward figure and 50 μM for enlarged figure).